CSCIF OTC
COSCIENS Biopharma Inc.
1W: +5.6%
1M: +29.3%
3M: -8.7%
YTD: +4.2%
$6.44
+0.02 (+0.31%)
Weekly Expected Move ±8.4%
$5
$6
$6
$7
$8
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$12M
+18.8% ▲
Capital Expenditures
$986K
+15.1% ▲
Free Cash Flow
-$13M
+18.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$59K
+63.1% ▲
Net Change in Cash
-$12M
-228.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2025 |
|---|---|
| — Operating Activities — | |
| Net Income | -$14M |
| Depreciation & Amort. | $2M |
| Stock-Based Comp. | $0 |
| Change in Working Capital | $408K |
| Other Non-Cash Items | $565K |
| Operating Cash Flow | -$12M |
| — Investing Activities — | |
| Capital Expenditures | -$986K |
| Acquisitions (Net) | $341K |
| Investment Purchases | $0 |
| Investment Sales | $6K |
| Other Investing | $0 |
| Investing Cash Flow | -$639K |
| — Financing Activities — | |
| Net Debt Issuance | $0 |
| Stock Repurchased | -$59K |
| Dividends Paid | $0 |
| Other Financing | -$510K |
| Financing Cash Flow | -$568K |
| Net Change in Cash | -$12M |
| Cash End of Period | $10M |
| Free Cash Flow | -$13M |